Product pack：50mg/7 tablets
Januvia 50 mg includes Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat adults with type 2 diabetes. Januvia 50 mg is used to treat type 2 diabetes in patients who are unable to regulate their blood sugar levels via diet and exercise alone. It is the first-line therapy for type 2 diabetes patients, restoring the body’s insulin responsiveness. Insulin is the hormone that regulates blood sugar levels. Individuals with type 2 diabetes either produce insufficient insulin or the insulin produced is unable to work properly in the body (insulin resistance). Type 2 diabetes is most commonly found in middle-aged or older adults, which is why it is also referred to as adult-onset diabetes.